Investment Summary

GIMV and Ernst Göhner Stiftung Invest In Spineart

On September 20, 2016, private equity firm GIMV and family office Ernst Göhner Stiftung invested in medical products company Spineart

Investment Highlights
  • This is GIMV’s 5th and Ernst Göhner Stiftung’s 1st transaction in the Medical Products sector.
  • This is GIMV’s 3rd and Ernst Göhner Stiftung’s 3rd transaction in Switzerland.

Investment Summary

Date 2016-09-20
Target Spineart
Sector Medical Products
Investor(s) GIMV
Ernst Göhner Stiftung
Deal Type Growth Capital

Target

Spineart

Plan-les-Ouates, Switzerland
Spineart is a Swiss medical device company focused on simplifying spinal surgery by designing, developing and promoting safe and efficient solutions to surgeons, operating room teams and patients. Spineart was founded in 2005 and is based in Plan-les-Ouates, Switzerland.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 2

Investor

GIMV

Antwerp, Belgium

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1980
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.


DEAL STATS #
Overall 105 of 170
Sector: Medical Products M&A 5 of 8
Type: Growth Capital M&A Deals 16 of 34
Country: Switzerland M&A 3 of 5
Year: 2016 M&A 10 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-14 Lampiris SA

Liège, Belgium

Lampiris SA is a provider of gas and green electricity to private, corporate and public sector customers. It holds a market share of 9% of the gas market and 6.5% of the electricity market, making it Belgium's third largest energy provider.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-25 MEGA International

Paris, France

MEGA International is a global software and consulting services company, which helps companies improve their business and IT agility to innovate in the digital world. The company offers a range of enterprise governance software solutions, called Hopex, to help its customers address challenges posed by regulation & compliance, IT complexity, enterprise transformation and new technologies. MEGA International was founded in 1991 and is based in Paris, France.

Buy -
DESCRIPTION

Ernst Göhner Stiftung (EGS) is an investment holding company that manages the investment activities of the Ernst Göhner Foundation. EGS looks to acquire long-term positions in Western European companies operating in basic industries. Ernst Göhner Stiftung is based in Zug, Switzerland.


DEAL STATS #
Overall 3 of 13
Sector: Medical Products M&A 1 of 1
Type: Growth Capital M&A Deals 1 of 1
Country: Switzerland M&A 3 of 13
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-25 Schild

Luzern, Switzerland

Schild is a Swiss fashion retailer for women's and men's clothing. Schild was founded in 1922 and is based in Luzern, Switzerland.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-01 Siegfried Holding

Zofingen, Switzerland

Siegfried Holding is a developer and manufacturer of active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediate steps and controlled substances, and provides development and production services for drugs in finished dosage forms including sterile filling. Siegfried Holding was founded in 1873 and is based in Zofingen, Switzerland.

Buy -